# NADC Supplement

> **NIH NIH P30** · WISTAR INSTITUTE · 2020 · $97,249

## Abstract

The Wistar Institute Cancer Center has undergone transformative changes during the last budget period that
reconfigured every administrative, scientific and educational segment of the organization. Coinciding with
the recruitment of Dr. Altieri as the first, dedicated Director of the Cancer Center, an inclusive, transparent
and highly consultative strategic planning process was completed in the last budget period. Emerging from
the 2012 Cancer Center Strategic Plan was a unifying vision to conquer cancer through outstanding
research, education and partnership and an underlying mission to merge basic, translational and patientoriented
cancer research in a single scientific continuum. The stepwise but decisive implementation of the
new strategic directives during the last budget period established a new administrative and decision-making
infrastructure of the Cancer Center, comprehensively realigned scientific Programs for optimal research
impact and synergistic collaboration, and reorganized Shared Resources as financially-sustainable engines
of Wistar discoveries. To enable the vision of the Cancer Center in translational and patient-oriented cancer
research, multidisciplinary, inter-programmatic initiatives were launched in the areas of melanoma and
ovarian cancer, and unique inter-institutional agreements were established with regional health systems for
access to clinically-annotated, primary patient specimens. Training the next generation of cancer scientists
became a strategic priority, fulfilled with the launch of a new, Wistar-based graduate program in cancer
biology and the deployment of expansive mentoring and career development tools for junior faculty. Against
this backdrop, the Cancer Center successfully recruited nine new faculty members at all academic ranks,
many of them research leaders, during the last budget cycle, grew its National Cancer Institute (NCI) funding
base by 21% from $8.1 million in 2008 to $10.2 million in 2013, and expanded its collaborative publications
from an average of 9.7% in 2008 to 29.3% in 2013 across all three scientific Programs. The extraordinary
growth of the past budget period, increased cancer focus, refinement of scientific themes and highly
collaborative environment have now placed the Cancer Center on a steep upward trajectory, ideally suited to
leverage the opening of a new, $102 million, seven story tall, Wistar Research Tower scheduled for the
summer of 2014. Providing for the largest faculty and facility expansion of Wistar in forty years, the new
Tbiver will enable the further development of focused and multidisciplinary flagship research themes in each
Program along the continuum of basic, translational and patient-oriented cancer research.

## Key facts

- **NIH application ID:** 9927586
- **Project number:** 5P30CA010815-51
- **Recipient organization:** WISTAR INSTITUTE
- **Principal Investigator:** Mohamed Abdel Mohsen
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $97,249
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9927586

## Citation

> US National Institutes of Health, RePORTER application 9927586, NADC Supplement (5P30CA010815-51). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/9927586. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*